A study out of the Smidt Heart Institute at Cedars-Sinai Medical Center suggests e-cigarettes—the culprit behind a vaping epidemic that’s injured more than 2,000 and claimed the lives of at least 39—could be more harmful to CV health than traditional cigarettes.

Nearly three-quarters of atrial fibrillation patients taking dabigatran remain adherent to the medication two years after filling their first prescription, while just over 25% discontinue the drug for various reasons, according to an analysis published in the American Journal of Cardiology.

Results from the world’s largest comprehensive study of hypertrophic cardiomyopathy patients are in—and they’re providing cardiologists with a wealth of previously unknown information about the disease.

Both severe and moderate aortic stenosis, when left untreated, were associated with poor long-term survival in a large-scale study of Australian heart patients.

The U.S. is seeing an uptick in the use of mechanical resuscitation devices despite a paucity of evidence that the digitized CPR tools are effective, researchers reported in JAMA Network Open this fall.

The 2010s saw a decrease in age-adjusted mortality associated with heart disease, according to a JAMA Cardiology report, but a concomitant rise in heart failure-related deaths and increase in the global population of adults over 65 actually resulted in an increase in the number of fatalities attributed to CVD.

Multiarterial CABG was linked to lower rates of long-term mortality, reintervention and MI than single-arterial CABG in a recent study of heart patients, suggesting the multiarterial approach is underused in contemporary practice.

Research published in JACC: Heart Failure Nov. 6 uncovered a worrying statistic in cardiology: Older patients who are hospitalized for heart failure could experience as much as a 12% increase in the number of HF-exacerbating medications they’re prescribed between admission and hospital discharge.